Immunohistochemical expression of androgen receptor and prostate-specific antigen in breast cancer

Folia Histochemica et Cytobiologica

Volumn 44, Issue 3, 2006, Pages 165-172

  Narita, Diana ^a   Raica, Marius ^a   Suciu, Cristian ^a   Cîmpean, Anca ^a   Anghel, Andrei ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Androgen receptor; Breast cancer; Prostate specific antigen

Indexed keywords

ANDROGEN RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BREAST CANCER; CANCER GRADING; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDULLARY CARCINOMA; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TUMOR DIFFERENTIATION;

EID: 33746542598     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Agoff SN, Swanson PE, Linden H (2003) Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical and prognostic associations. Am J Clin Pathol 120: 725-731
2. Alanen KA, Knopio T, Collan YU, Kronqvist P, Juntti L (1999) Immunohistochemical labeling for prostate-specific antigen in breast carcinomas. Breast Cancer Res Treat 56: 169-176
3. Bayer-Gamer IB, Smoller B (2000) Androgen receptors: A marker of increase sensitivity for identifying breast cancer in skin metastasis of unknown primary site. Mod Pathol 13: 119-122
4. Bharaj B, Scorilas A, Diamandis EP, Giai M, Levesque MA (2000) Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoter. Breast Cancer Res Treat 61: 111-119
5. Bieche I, Parfait B, Tozlu S, Lidereau R, Vidaud M (2001) Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR: Evidence that MYC is an AR-regulated gene. Carcinogenesis 22: 1521-1526
6. Birrell SN, Bemtel JM, Hickey TE, Ricciardelli C, Weger MA, Horsfall DJ, Tilley WD (1995) Androgens induce divergent proliferative responses in human breast cancer cell lines. J Steroid Biochem Mol Biol 52: 459-467
7. Black Margot H, Diamandis EP (2000) The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast. Breast Cancer Res Treat 59: 1-14
8. Bodey B, Bodey B Jr, Kaiser HE (1997) Immunocytochemical detection of prostate specific antigen expression in human breast carcinoma cells. Anticancer Res 17: 2577-2581
9. Buchanan G, Birrell SN, Peters A, Bianco-Miotto T, Ramsay K, Cops EJ, Yang M, Harris, J, Simila H, Moore N, Bentel J, Ricciardelli C, Horsfall D, Butler L, Tilley W (2005) Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate. Cancer Res 65: 8487-8496
10. Diamandis EP, Helle SJ, Yu H, Melegos DN, Lundgren S, Lonning PE (1999) Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinoma. Cancer 85: 891-898
11. Diamandis EP, Yu H, Sutherland DJ (1994) Detection of prostate-specific antigen immunoreactivity in breast tumors. Breast Cancer Res Treat 32: 301-310
12. Diamandis EP, Yu H (1997) Nonprostatic sources of prostate-specific antigen. Urol Clin North Am 24: 275-282
13. Ellis IO, Dowsett M, Bartlett J, Walker R, Cooke T (2000) Recommendations for HER2 testing in the UK. J Clin Pathol 53: 890-892
14. Ellis LM, Wittliff L, BryantMS (1989) Correlation of estrogen, progesterone and androgen receptors in breast cancer. Am J Surg 157: 577-581
15. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 19: 403-410
16. Foekens JA, Diamandis EP, Yu H, Look MP, Meijer-van Gelder ME, van Putten WLJ (1999) Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer. Br J Cancer 79: 888-894
17. Gatalica Z (1997) Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ. Pathol Res Pract 193: 753-758
18. Hackenberg R, Schultz KD (1996) Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids. J Steroid Biochem Mol Biol 56: 113-117
19. Hall RE, Clements JA, Birrel SN, Tilley WD (1998) Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast. Br J Cancer 78: 360-365
20. Heyl W, Wolff JM, Biesterfeld S (1999) Immunohistochemical analysis of prostate-specific antigen does not correlate to other prognostic factors in breast cancer. Anticancer Res 19: 2563-2565
21. Howarth DJ, Aronson IB, Diamandis EP (1997) Immunohistochemical localization of prostate-specific antigen in benign and malignant breast tissues. Br J Cancer 75: 1646-1651
22. Isola JJ (1993) Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors. J Pathol 170: 31-35
23. Kimura N, Mizokami A, Oonuma T, Sasano H, Nagura H (1993) Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues. J Histochem Cytochem 41: 671-678
24. Kuenen-Boumeester V, Van Der Kwast TH, Claassen CC, Look MP, Liem GS, Klijn JGM, Henzen-Logmans SC (1996) The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters. Eur J Cancer 32A: 1560-1565
25. Leal C, Henrique R, Monteiro P, Lopes C, Bento MJ, De Sousa CP, Lopes P, Olson S, Silva MD, Page DL (2001) Apocrine ductal carcinoma in situ of the breast: Histologic classification and expression of biologic markers. Hum Pathol 32: 487-493
26. Liegl B, Horn LC, Moinfar F (2005) Androgen receptors are frequently expressed in mammary and extramammary Paget's disease. Mod Pathol 18: 1283-1288
27. Magklara A, Brown TJ, Diamandis EP (2002) Characterization of androgen receptor and nuclear receptor co-regulator expression in human breast cancer cell lines exhibiting differential regulation of kallikreins 2 and 3. Int J Cancer 100: 507-514
28. Majumdar S, Diamandis EP (1999) The promoter and the enhancer region of the prostate-specific antigen of the KLK3 (prostate-specific antigen) gene is frequently mutated in breast tumors and in breast carcinoma cell lines. Br J Cancer 79: 1594-1602
29. Mannello F, Bocchiotti G, Bianchi G, Marcheggiani F, Gazzanelli G (1996) Quantification of prostate-specific antigen immunoreactivity in human breast cyst fluids. Breast Cancer Res Treat 38: 247-252
30. Mannello F, Gazzanelli G (2001) Prostate-specific antigen (PSA/hK3): A further player in the field of breast cancer diagnostics? Breast Cancer Res 3: 238-243
31. Miller MK, Unger PD, Bleiweiss IJ (2001) Immunohistochemical analysis of prostate specific antigen in breast cancer. Breast Cancer Res Treat 68: 111-116
32. Moinfar F, Okcu M, Tsybrovskyy O, Regitnig P, Lax S, Weybora W, Ratschek M, Tavassoli F, Denk H (2003) Androgen receptors frequently are expressed in breast carcinomas. Potential relevance to new therapeutic strategies. Cancer 98: 703-711
33. Monne M, Croce CM, Yu H, Diamandis EP (1994) Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors. Cancer Res 54: 6344-6347
34. Narita D, Raica M, Anghel A, Suciu C, Cmpean AM (2005) Immunohistochemical localization of prostate-specific antigen in benign and malignant breast conditions. Rom J Morphol Embryol 46: 41-45
35. Ortmann J, Prifti S, Bohlmann MK, Rehberger-Schneider S, Strowitzki T, Rabe T (2002) Testosterone and 5α-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines. Gynecol Endocrinol 16: 113-120
36. Papotti M, Paties C, Peveri V (1989) Immunocytochemical detection of prostate-specific antigen in skin adnexae and breast tissues and tumors. Basic Appl Histochem 33: 25-29
37. Parish DC (1998) Prostate-specific antigen in the breast. Endocr Relat Cancer 5: 223-229
38. Riva C, Dainese E, Caprara G, Rocca PC, Massarelli G, Tibor T, Capella C, Eusebi V (2005) Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma. Virchows Arch 447: 695-700
39. Sauter ER, Klein G, Wagner-Mann C, Diamandis EP (2004) Prostate-specific antigen expression in nipple aspirate fluid is associated with advanced breast cancer. Cancer Detect Prev 28: 27-31
40. Selim A, El-Ayat G, Wells CA (2002) Androgen receptor expression in ductal carcinoma in situ of the breast: Relation to oestrogen and progesterone receptors. J Clin Pathol 55: 14-16
41. Somboonporn W, Davis S (2004) Testosterone effects on the breast: implications for testosterone therapy for women. Endocr Rev 25: 374-388
42. Tanaka A, Kamiakito T, Takayashiki N, Sakurai S, Saito K (2002) Fibroblast growth factor 8 expression in breast carcinoma: Associations with androgen receptor and prostate specific antigen expressions. Virchows Arch 441: 380-394
43. Tsung JS, Wang TY, Wang SM, Yang PS (2005) Cytological and biochemical studies of breast cyst fluid. Breast 14: 37-41
44. Yang Q, Nakamura M, Nakamura Y, Yoshimura G, Suzuma T (2002) Correlation of prostate-specific antigen promoter polymorphism with clinicopathological characteristics in breast cancer. Anticancer Res 22: 1825-1828
45. Yao GY, Zhou JL, Zhao ZS (2004) Biological characteristics of breast carcinomas with neuroendocrine cell differentiation. Chin Med J 117: 1536-1540
46. Yu H, Diamandis EP, Levesque M (1996) Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue. Breast Cancer Res Treat 40: 171-178
47. Yu H, Giai M, Diamandis EP (1995) Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res 55: 2104-2110
48. Yu H, Levesque MS, Clark GM, Diamandis EP (1998) Prognostic value of prostate-specific antigen for women with breast cancer. A large United States cohort study. Clin Cancer Res 4: 1489-1497
49. Zarghami N, Grass L, Diamandis EP (1997) Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer. Br J Cancer 74: 579-588
50. Zhou J, Ng S, Adesanya-Famuiya O, Anderson K, Bondy CA (2000) Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression. FASEB J 14: 1725-1730